166 related articles for article (PubMed ID: 19381163)
1. Pharmacogenetics and biomarkers in colorectal cancer.
Strimpakos AS; Syrigos KN; Saif MW
Pharmacogenomics J; 2009 Jun; 9(3):147-60. PubMed ID: 19381163
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics and -genetics in colorectal cancer.
Pohl A; Lurje G; Manegold PC; Lenz HJ
Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics in chemotherapy of colorectal cancer.
Henriette Tanja L; Guchelaar HJ; Gelderblom H
Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
[TBL] [Abstract][Full Text] [Related]
4. Using genetic variation to optimize cancer chemotherapy.
McLeod HL; Papageorgio C; Watters JW
Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
[TBL] [Abstract][Full Text] [Related]
5. Role of pharmacogenetics as predictive biomarkers of response and/or toxicity in the treatment of colorectal cancer.
Bhushan S; McLeod H; Walko CM
Clin Colorectal Cancer; 2009 Jan; 8(1):15-21. PubMed ID: 19203892
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of colorectal cancer prevention and treatment.
Nguyen H; Tran A; Lipkin S; Fruehauf JP
Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics and therapeutic strategies for dementia.
Cacabelos R
Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for response to chemotherapy in colorectal cancer patients.
Vincenzi B; Cesa AL; Santini D; Schiavon G; Grilli C; Graziano F; Tonini G
Crit Rev Oncol Hematol; 2004 Oct; 52(1):45-60. PubMed ID: 15363466
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.
Russo A; Corsale S; Cammareri P; Agnese V; Cascio S; Di Fede G; Macaluso M; Bazan V
J Cell Physiol; 2005 Sep; 204(3):742-9. PubMed ID: 15828025
[TBL] [Abstract][Full Text] [Related]
10. [Genomic markers and anticancer chemotherapy].
Nishiyama M
Gan To Kagaku Ryoho; 2008 Feb; 35(2):194-9. PubMed ID: 18281756
[TBL] [Abstract][Full Text] [Related]
11. Implications of genetic testing in the management of colorectal cancer.
Stoehlmacher J; Lenz HJ
Am J Pharmacogenomics; 2003; 3(2):73-88. PubMed ID: 12749725
[TBL] [Abstract][Full Text] [Related]
12. Applications of genomic tools to colorectal cancer therapeutics.
Auman JT; McLeod HL
Curr Opin Mol Ther; 2008 Dec; 10(6):548-54. PubMed ID: 19051132
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic biomarkers of colorectal cancer.
Choong MK; Tsafnat G
Clin Gastroenterol Hepatol; 2012 Jan; 10(1):9-15. PubMed ID: 21635968
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic aspects in treatment of colorectal cancer--an update.
Stoehlmacher J; Goekkurt E; Lenz HJ
Pharmacogenomics; 2003 Nov; 4(6):767-77. PubMed ID: 14596640
[TBL] [Abstract][Full Text] [Related]
15. [Molecule based diagnosis].
Akaza H; Ichikawa T; Tsuruo T; Shimada Y; Moriwaki H; Mori M; Noguchi S; Nakamura S; Saijo N; Sone S; Isonishi S; Ohashi Y; Hinotsu S; von Euler M; Blackedge G
Gan To Kagaku Ryoho; 2004 Jan; 31(1):125-33. PubMed ID: 14750337
[TBL] [Abstract][Full Text] [Related]
16. Interpreting disparate responses to cancer therapy: the role of human population genetics.
Maitland ML; DiRienzo A; Ratain MJ
J Clin Oncol; 2006 May; 24(14):2151-7. PubMed ID: 16682733
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers and targets for colorectal cancer prevention.
Janakiram NB; Rao CV
Acta Pharmacol Sin; 2008 Jan; 29(1):1-20. PubMed ID: 18158862
[TBL] [Abstract][Full Text] [Related]
18. Factors involved in clinical pharmacology variability in oncology (review).
Chabot GG
Anticancer Res; 1994; 14(6A):2269-72. PubMed ID: 7825957
[TBL] [Abstract][Full Text] [Related]
19. Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI.
Wang SJ
Pharm Stat; 2007; 6(4):283-96. PubMed ID: 17957727
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics in clinical practice: considerations for testing.
Constable S; Johnson MR; Pirmohamed M
Expert Rev Mol Diagn; 2006 Mar; 6(2):193-205. PubMed ID: 16512779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
